Wood, Lily
Martin, Christopher
Polly, David
Luchsinger, Samuel
Takahashi, Takashi http://orcid.org/0000-0002-3323-7069
Article History
Received: 11 October 2020
Accepted: 22 April 2021
First Online: 17 May 2021
Declarations
:
: This study was reviewed by the University of Minnesota’s Institutional Review Board and was determined to be exempt from further review under federal guidelines 45 CFR Part 46.110. The IRB waived the requirement of informed consent, as allowed by 45 CFR 46.116 (d): Research involving no more than minimal risk to the subjects.
: Not applicable.
: Dr’s. Christopher Martin, Samuel Luchsinger and Takashi Takahashi have no relevant financial or non-financial interests to disclose. Dr. Lily Wood’s disclosures: Immediate family member is employed by and holds stock in Dyne Therapeutics. Dr. David W. Polly’s disclosures: Consultant-SI Bone; Royalties -Springer (textbook); Research support paid to institution-MizuhoOSI and Medtronic; Royalties paid to institution-Medtronic and Globus; Speaking-Globus.